Gestational Diabetes
Gestational diabetes is a condition characterized by high blood sugar levels that develop during pregnancy, typically in the second trimester, due to insulin resistance. While it often presents few symptoms, it can increase the risk of complications such as pre-eclampsia, need for a Caesarean section, and various health issues for the baby, both immediately after birth and later in life.
Health Outcomes
- Absence of Adverse Pregnancy Complications
- Changed Maternal Plasma Fatty Acids
- Characterized Carbohydrate Metabolism Enzyme Activity
- Diabetes Progression
- Distinct Metabolic Profile
- Improved Blood Glucose Concentration
- Improved Blood Glucose Levels
- Improved Endocrine Function
- Improved Exclusive Breastfeeding Rate
- Improved Glycemic Control
- Improved Glycemic Response
- Improved HbA1c
- Improved Insulin Levels
- Improved Insulin Response
- Improved Insulin Secretion
- Improved Insulin Secretion Rate
- Improved Live Birth Rate
- Improved Maternal Health
- Improved Maternal Metabolic Health
- Improved Metabolic Homeostasis
- Improved Perinatal Safety
- Improved Physiological Status in Offspring
- Improved Pregnancy-Related Wellbeing
- Improved Safety in Pregnant Women
- Increased Birth Length
- Increased Birth Weight
- Increased Birthweight
- Increased Blood Glucose Levels
- Increased Fasting Insulin Level
- Increased GLP-1 Levels
- Increased Glucagon-Like Peptide 1 Level
- Increased Glucose Utilization During Feed Restriction
- Increased Growth in Newborns
- Increased Infant Weight
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Milk Component Concentrations
- Increased PGDH Expression in Female Placentae
- Increased Proportion with Normalized Hemoglobin A1c
- Increased Reversion to Normoglycemia
- Increased Serum Insulin Levels
- Influence on Infant Weight
- Maintained Glucose Control
- Modified Fetal Brain Metabolism
- No Adverse Events from Supplementation
- No Change in Metabolic Health
- No Improvement in Adverse Pregnancy Outcomes
- Normal Pregnancy Outcomes
- Preserved Pancreatic Beta-Cell Function
- Prolonged Gestation
- Reduced Alpha-cell Expansion
- Reduced Beta Cell Function
- Reduced Fasting Insulin Level
- Reduced Fetal Loss
- Reduced First Phase Insulin Secretion
- Reduced Glucose Area Under the Curve
- Reduced Glycated Hemoglobin
- Reduced Glycated Hemoglobin A1c Level
- Reduced Glycemic Enzyme Inhibition
- Reduced Glycemic Index
- Reduced Glycemic Response
- Reduced HOMA-IR
- Reduced HOMA-β
- Reduced HbA1c Level
- Reduced Insulin Output (90-min)
- Reduced Insulin Requirement
- Reduced Intrauterine Fetal Demise
- Reduced Maternal Mortality
- Reduced Metabolic Dysregulation
- Reduced Neonatal Hypoglycemia
- Reduced Neonatal Risk
- Reduced Peak Plasma Glucose Level
- Reduced Perinatal Loss
- Reduced Postpartum Hemorrhage Rate
- Reduced Postprandial Blood Glucose
- Reduced Postprandial Blood Glucose Level
- Reduced Postprandial Blood Glucose Rise
- Reduced Postprandial Glucose Response
- Reduced Postprandial Glycemia
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Pre-eclampsia
- Reduced Pregnancy Disorder Risk
- Reduced Preterm Birth Rate
- Reduced Preterm Births
- Reduced Prevalence of Gestational Diabetes Mellitus
- Reduced Rate of Preterm Births Under 34 Weeks
- Reduced Risk of Infant Health Problems
- Reduced Risk of Preeclampsia
- Reduced Risk of Small-for-Gestational-Age Birth
- Reduced Small-for-Gestational-Age
- Reduced Stillbirth
- Reduced Taurodeoxycholic Acid in Women with GDM
- Reduced Total Glycated Hemoglobin
- Reduced Two-Hour Postprandial Glucose
- Regulated Blood Glucose Levels
- Safety During Pregnancy
- Stabilized Blood Glucose Level
- Stabilized Hemoglobin A1c Level
- Successful Pregnancy Outcome
- Tolerability of Probiotics in Pregnancy
- Unchanged Gestational Glycemia
- Unchanged Glycemic Control
- Unchanged Insulin Resistance
- Unchanged Waist-to-Hip Ratio